SciELO - Scientific Electronic Library Online

 
vol.20 número1Análisis de la casuística de los pacientes derivables desde urgencias a atención primariaEvaluación económica del tratamiento con ácido acetilsalicílico más esomeprazol comparado con clopidogrel en la prevención de la hemorragia gastrointestinal índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Gaceta Sanitaria

versão impressa ISSN 0213-9111

Resumo

MAR, Javier; GUTIERREZ-MORENO, Santiago  e  CHILCOTT, Jim. Probabilistic cost-effectiveness analysis of the treatment of sleep apnea. Gac Sanit [online]. 2006, vol.20, n.1, pp.47-53. ISSN 0213-9111.

Objective: To describe the application of a probabilistic cost-effectiveness analysis to nasal continuous positive airway passage (nCPAP) treatment of obstructive sleep apnea syndrome (OSAS). Material and Methods: The probabilistic model was constructed from a discrete Markov model. This probabilistic approach is characterized by the introduction of variables as probability distributions. The model performed 2,000 Monte Carlo simulations, and incremental costs and effectiveness were calculated in each. The results were analyzed through the cost-effectiveness plane, the acceptability curve, the net benefit rule, and the expected value of perfect information (EVPI). Results: The mean cost-effectiveness ratio for nCPAP treatment was 5,480 S/QALY (quality-adjusted life year). Using an acceptability threshold of 30,000 €/QALY, the probabilistic analysis showed that nCPAP was the optimal treatment in 98.5% of the simulations. The EVPI showed that the parameter causing greatest uncertainty in the final results was the quality of life gain through nCPAP treatment. Conclusions: The results of our probabilistic analysis are endorsed by previous deterministic studies confirming that nCPAP treatment of OSAS is the most cost-effective strategy. An additional advantage of probabilistic analysis is that it allows uncertainty to be quantified; in the present case the probability of making the wrong decision was below 5%. Furthermore, this study reveals that to reduce uncertainty, research should center on improving information on quality of life.

Palavras-chave : Obstructive sleep apnea syndrome; Treatment; Cost-effectiveness analysis; Monte Carlo simulations.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons